Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependencySarah Aminov, Amit Verma, David T. Melnekoff et al.|Journal of Clinical Investigation|2024Cited by 20